Antifungal prophylaxis for intensive care unit patients: let's fine tune it.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: a systematic review and meta-analysis.Intensive care medicine · 2005
   Pooled it
2. Comment on "Prevention of severe Candida infections in non-neutropenic, high-risk, critically ill patients," by Garbino et al.Intensive care medicine · 2003
   Trial
3. Caspofungin for prevention of intra-abdominal candidiasis in high-risk surgical patients.Intensive care medicine · 2009
   Article
4. Multidisciplinary approach to the treatment of invasive fungal infections in adult patients. Prophylaxis, empirical, preemptive or targeted therapy, which is the best in the different hosts?Therapeutics and clinical risk management · 2008
   Article
5. Epidemiology of invasive candidiasis: a persistent public health problem.Clinical microbiology reviews · 2007
   Review
6. Practices in non-neutropenic ICU patients with Candida-positive airway specimens.Intensive care medicine · 2004
   Article

Corrections and comments

• Comment on
  Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination.2002

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as